These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29887449)

  • 1. Iron deficiency without anemia is responsible for decreased left ventricular function and reduced mitochondrial complex I activity in a mouse model.
    Rineau E; Gaillard T; Gueguen N; Procaccio V; Henrion D; Prunier F; Lasocki S
    Int J Cardiol; 2018 Sep; 266():206-212. PubMed ID: 29887449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron Deficiency without Anemia Decreases Physical Endurance and Mitochondrial Complex I Activity of Oxidative Skeletal Muscle in the Mouse.
    Rineau E; Gueguen N; Procaccio V; Geneviève F; Reynier P; Henrion D; Lasocki S
    Nutrients; 2021 Mar; 13(4):. PubMed ID: 33805065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet-Induced Metabolic Heart Disease.
    Sverdlov AL; Elezaby A; Qin F; Behring JB; Luptak I; Calamaras TD; Siwik DA; Miller EJ; Liesa M; Shirihai OS; Pimentel DR; Cohen RA; Bachschmid MM; Colucci WS
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26755553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure.
    Haddad S; Wang Y; Galy B; Korf-Klingebiel M; Hirsch V; Baru AM; Rostami F; Reboll MR; Heineke J; Flögel U; Groos S; Renner A; Toischer K; Zimmermann F; Engeli S; Jordan J; Bauersachs J; Hentze MW; Wollert KC; Kempf T
    Eur Heart J; 2017 Feb; 38(5):362-372. PubMed ID: 27545647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
    N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
    Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.
    Boudina S; Bugger H; Sena S; O'Neill BT; Zaha VG; Ilkun O; Wright JJ; Mazumder PK; Palfreyman E; Tidwell TJ; Theobald H; Khalimonchuk O; Wayment B; Sheng X; Rodnick KJ; Centini R; Chen D; Litwin SE; Weimer BE; Abel ED
    Circulation; 2009 Mar; 119(9):1272-83. PubMed ID: 19237663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
    Anker SD; Kirwan BA; van Veldhuisen DJ; Filippatos G; Comin-Colet J; Ruschitzka F; Lüscher TF; Arutyunov GP; Motro M; Mori C; Roubert B; Pocock SJ; Ponikowski P
    Eur J Heart Fail; 2018 Jan; 20(1):125-133. PubMed ID: 28436136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*.
    Heming N; Lettéron P; Driss F; Millot S; El Benna J; Tourret J; Denamur E; Montravers P; Beaumont C; Lasocki S
    Crit Care Med; 2012 Jul; 40(7):2141-8. PubMed ID: 22564959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency.
    Suzuki T; Hanawa H; Jiao S; Ohno Y; Hayashi Y; Yoshida K; Kashimura T; Obata H; Minamino T
    J Card Fail; 2014 Apr; 20(4):268-77. PubMed ID: 24440572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency.
    Ponikowski P; van Veldhuisen DJ; Comin-Colet J; Ertl G; Komajda M; Mareev V; McDonagh TA; Parkhomenko A; Tavazzi L; Levesque V; Mori C; Roubert B; Filippatos G; Ruschitzka F; Anker SD
    ESC Heart Fail; 2014 Sep; 1(1):52-58. PubMed ID: 28834668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR
    Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.
    Toblli JE; Angerosa M
    Drug Des Devel Ther; 2014; 8():2475-91. PubMed ID: 25525337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
    Onken JE; Bregman DB; Harrington RA; Morris D; Buerkert J; Hamerski D; Iftikhar H; Mangoo-Karim R; Martin ER; Martinez CO; Newman GE; Qunibi WY; Ross DL; Singh B; Smith MT; Butcher A; Koch TA; Goodnough LT
    Nephrol Dial Transplant; 2014 Apr; 29(4):833-42. PubMed ID: 23963731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early effects on T lymphocyte response to iron deficiency in mice. Short communication.
    Saldanha-Araujo F; Souza AM
    Biol Trace Elem Res; 2009 Feb; 127(2):95-101. PubMed ID: 18825318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells.
    Kuvibidila SR; Kitchens D; Baliga BS
    J Cell Biochem; 1999 Sep; 74(3):468-78. PubMed ID: 10412047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron status influences mitochondrial disease progression in Complex I-deficient mice.
    Kelly CJ; Couch RK; Ha VT; Bodart CM; Wu J; Huff S; Herrel NT; Kim HD; Zimmermann AO; Shattuck J; Pan YC; Kaeberlein M; Grillo AS
    Elife; 2023 Feb; 12():. PubMed ID: 36799301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function.
    Hoes MF; Grote Beverborg N; Kijlstra JD; Kuipers J; Swinkels DW; Giepmans BNG; Rodenburg RJ; van Veldhuisen DJ; de Boer RA; van der Meer P
    Eur J Heart Fail; 2018 May; 20(5):910-919. PubMed ID: 29484788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac remodeling in response to chronic iron deficiency: role of the erythropoietin receptor.
    Naito Y; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Morisawa D; Eguchi A; Hirotani S; Mano T; Tsujino T; Masuyama T
    J Hypertens; 2015 Jun; 33(6):1267-75. PubMed ID: 25715089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
    Shim JY; Kim MY; Kim YJ; Lee Y; Lee JJ; Jun JK; Shin JC; Cho YK; Lee KY; Kim A; Song TB
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):349. PubMed ID: 30153811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.